{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:49:10Z","timestamp":1791427750281,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41443-019-0138-7","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T13:04:16Z","timestamp":1555592656000},"page":"201-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-fibrotic effect of mycophenolate mofetil on Peyronie\u2019s disease experimentally induced with TGF-\u03b2"],"prefix":"10.1038","volume":"32","author":[{"given":"Thiago","family":"Antoniassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Nestor F\u00e1cio","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Cesar Fava","family":"Spessoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana Spegorin","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e3o","family":"Taboga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"138_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5534\/wjmh.2016.34.2.65","volume":"34","author":"GA Joice","year":"2016","unstructured":"Joice GA, Burnett AL. Nonsurgical interventions for Peyronie\u2019s disease: update as of 2016. World J Mens Health. 2016;34:65\u201372.","journal-title":"World J Mens Health"},{"key":"138_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5152\/tud.2016.40799","volume":"42","author":"RA Talib","year":"2016","unstructured":"Talib RA, Ibrahim MA, Cang\u00fcven \u00d6. Nonsurgical treatment options in Peyronie\u2019s Disease: 2016 update. Turk J Urol. 2016;42:217\u201323.","journal-title":"Turk J Urol"},{"key":"138_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/tau.2016.04.05","volume":"5","author":"S Al-Thakafi","year":"2016","unstructured":"Al-Thakafi S, Al-Hathal N. Peyronie\u2019s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol. 2016;5:280\u20139.","journal-title":"Transl Androl Urol"},{"key":"138_CR4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","volume":"7","author":"R Tal","year":"2010","unstructured":"Tal R, Heck M, Teloken P, Siegrist T, Nelson CJ, Mulhall JP. Peyronie\u2019s disease following radical prostatectomy: incidence and predictors. J Sex Med. 2010;7:1254\u201361.","journal-title":"J Sex Med"},{"key":"138_CR5","first-page":"131","volume":"5","author":"TS Antoniassi","year":"2016","unstructured":"Antoniassi TS, Spessoto LCF, Gon\u00e7alves Filho JR, Cavalcante VMM, da Silva EA, Facio MFW, et al. Risk factors for Peyronie\u2019s disease in patients submitted to the Nesbit procedure. Int J Sci. 2016;5:131\u20133.","journal-title":"Int J Sci"},{"key":"138_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","volume":"7","author":"AN Bilgutay","year":"2015","unstructured":"Bilgutay AN, Pastuszak AW. Peyronie\u2019s disease: a review of etiology, diagnosis and management. Curr Sex Health Rep. 2015;7:117\u201331.","journal-title":"Curr Sex Health Rep"},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ncpuro0201","volume":"2","author":"NF Gonzalez-Cadavid","year":"2005","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie\u2019s disease. Nat Clin Pract Urol. 2005;2:291\u20137.","journal-title":"Nat Clin Pract Urol"},{"key":"138_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1743-6109.2008.01104.x","volume":"6","author":"NF Gonzalez-Cadavid","year":"2009","unstructured":"Gonzalez-Cadavid NF, Rajfer J. Experimental models of Peyronie\u2019s disease. Implications for new therapies. J Sex Med. 2009;6:303\u201313.","journal-title":"J Sex Med"},{"key":"138_CR9","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0022-5347(01)68236-3","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Chui RM, Bhatnagar RS, Dahiya R, Lue TF. An animal model of Peyronie\u2019s-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol. 1997;158:2284\u201390.","journal-title":"J Urol"},{"key":"138_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0022-5347(17)40920-7","volume":"141","author":"KD Somers","year":"1989","unstructured":"Somers KD, Sismour EN, Wright GL Jr, Devine CJ Jr, Gilbert DA, Horton CE. Isolation and characterization of collagen in Peyronie\u2019s Disease. J Urol. 1989;141:629\u201331.","journal-title":"J Urol"},{"key":"138_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0022-5347(17)36630-2","volume":"148","author":"R Luangkhot","year":"1992","unstructured":"Luangkhot R, Rutchik S, Agarwal V, Puglia K, Bhargava G, Melman A. Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol. 1992;148:467\u201371.","journal-title":"J Urol"},{"key":"138_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/j.1939-4640.2000.tb03387.x","volume":"21","author":"WJ Hellstrom","year":"2000","unstructured":"Hellstrom WJ, Bivalacqua TJ. Peyronie\u2019s disease: etiology, medical, and surgical therapy. J Androl. 2000;21:347\u201354.","journal-title":"J Androl"},{"key":"138_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.eururo.2012.09.034","volume":"63","author":"F Castiglione","year":"2013","unstructured":"Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, et al. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie\u2019s disease. Eur Urol. 2013;63:551\u201360.","journal-title":"Eur Urol"},{"key":"138_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1124\/jpet.106.117051","volume":"321","author":"N Roos","year":"2007","unstructured":"Roos N, Poulalhon N, Farge D, Madelaine I, Mauviel A, Verrecchia F. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil. J Pharm Exp Ther. 2007;321:583\u20139.","journal-title":"J Pharm Exp Ther"},{"key":"138_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.juro.2007.03.057","volume":"178","author":"PJ Scheel Jr","year":"2007","unstructured":"Scheel PJ Jr, Piccini J, Rahman MH, Lawler LJ. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol. 2007;178:140\u20133.","journal-title":"J Urol"},{"key":"138_CR16","first-page":"283","volume":"123","author":"PJ Scheel Jr","year":"2012","unstructured":"Scheel PJ Jr, Sozio SM, Feeley N. Medical management of retroperitoneal fibrosis. Trans Am Clin Clim Assoc. 2012;123:283\u201390.","journal-title":"Trans Am Clin Clim Assoc"},{"key":"138_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ajur.2015.04.019","volume":"2","author":"AA Hussein","year":"2015","unstructured":"Hussein AA, Alwall A, Lue TF. All about Peyronie\u2019s disease. Asian J Urol. 2015;2:70\u20138.","journal-title":"Asian J Urol"},{"key":"138_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","volume":"81","author":"AI El-Sakka","year":"1998","unstructured":"El-Sakka AI, Hassan MU, Nunes L, Bhatnagar RS, Yen TS, Lue TF. Histological and ultrastructural alterations in an animal model of Peyronie\u2019s disease. Br J Urol. 1998;81:445\u201352.","journal-title":"Br J Urol"},{"key":"138_CR19","doi-asserted-by":"publisher","first-page":"849035","DOI":"10.1155\/2011\/849035","volume":"2011","author":"A Tzouvelekis","year":"2011","unstructured":"Tzouvelekis A, Bouros E, Oikonomou A, Ntolios P, Zacharis G, Kolios G, et al. Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. Pulm Med. 2011;2011:849035.","journal-title":"Pulm Med"},{"key":"138_CR20","unstructured":"American Veterinary Medical Association. Guideline for the Euthanasia of animals: ed. 2013; p.48. https:\/\/www.avma.org\/KB\/Policies\/Documents\/euthanasia.pdf ."},{"key":"138_CR21","unstructured":"Behmer AO, Tolosa EMC, Neto AGF. Manual de pr\u00e1ticas para histologia normal e patol\u00f3gica. S\u00e3o Paulo: EDART-EDUSP; 1976. p. 329."},{"key":"138_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/BF02473274","volume":"106","author":"HF Carvalho de","year":"1996","unstructured":"de Carvalho HF, Taboga SR. Fluorescence and confocal laser scanning microscopy imaging of elastic fibers in hematoxylin-eosin stained sections. Histochem Cell Biol. 1996;106:587\u201392.","journal-title":"Histochem Cell Biol"},{"key":"138_CR23","first-page":"131","volume":"12","author":"ER Weibel","year":"1978","unstructured":"Weibel ER. Principles and methods for the morphometric study of the lung and other organs. Lab Invest. 1978;12:131\u201355.","journal-title":"Lab Invest"},{"key":"138_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0970-1591.173107","volume":"32","author":"AN Bilgutay","year":"2016","unstructured":"Bilgutay AN, Pastuszak AW. Peyronie\u2019s disease: what\u2019s around the bend? Indian J Urol. 2016;32:6\u201314.","journal-title":"Indian J Urol"},{"key":"138_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.2047-2927.2013.00181.x","volume":"2","author":"A Gokce","year":"2014","unstructured":"Gokce A, Abd Elmageed ZY, Lasker GF, Bouljihad M, Kim H, Trost LW, et al. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie\u2019s disease. Andrology. 2014;2:244\u201351.","journal-title":"Andrology"},{"key":"138_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/aja.2012.92","volume":"15","author":"LA Levine","year":"2013","unstructured":"Levine LA, Larsen SM. Surgery for Peyronie\u2019s disease. Asian J Androl. 2013;15:27\u201334.","journal-title":"Asian J Androl"},{"key":"138_CR27","first-page":"30477","volume":"S0090-4295","author":"WJG Hellstrom","year":"2017","unstructured":"Hellstrom WJG, Tan RBW, Liu G. Safety profile of collagenase Clostridium histolyticum stratified by degree of penile curvature in patients with Peyronie\u2019s disease. Urology. 2017;S0090-4295:30477\u20136.","journal-title":"Urology"},{"key":"138_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"138_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.21037\/tau.2016.12.08","volume":"6","author":"S Yan","year":"2017","unstructured":"Yan S, Yap T, Minhas S. Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie\u2019s disease: a safety profile. Transl Androl Urol. 2017;6:123\u20136.","journal-title":"Transl Androl Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-019-0138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-019-0138-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-019-0138-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T02:10:50Z","timestamp":1721182250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-019-0138-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1038\/s41443-019-0138-7","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}